Rapid Micro Biosystems (RPID) Net Equity Issued and Repurchased (2020 - 2021)
Rapid Micro Biosystems (RPID) posted Net Equity Issued and Repurchased of $243000.0 for Q2 2021, down 99.69% sequentially from $79.5 million in Q1 2021, and down 99.09% YoY from $26.6 million in Q2 2020.
Rapid Micro Biosystems (RPID) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
Rapid Micro Biosystems has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $243000.0 in Q2 2021.
- Quarterly Net Equity Issued and Repurchased fell 99.09% year-over-year to $243000.0 in Q2 2021, while the trailing twelve-month figure through Dec 2022 was $243000.0 (down 99.7% YoY) and the FY2025 annual result came in at $445000.0, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to $243000.0 in Q2 2021 per RPID's latest filing, from $79.5 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $79.5 million in Q1 2021 and troughed at $243000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 243,000.00 |
| Jun 30, 2021 | 243,000.00 |
| Mar 31, 2021 | 79.50 Mn |
| Mar 31, 2021 | 79.50 Mn |
| Jun 30, 2020 | 26.64 Mn |
| Jun 30, 2020 | 26.64 Mn |